Evidence map›Paper›PMID 21145581›Full record

ArticleLancet (London, England)2011

Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.

Mercedes C Becerra, Sasha C Appleton, Molly F Franke, Katiuska Chalco, Fernando Arteaga, Jaime Bayona, Megan Murray, Sidney S Atwood, Carole D Mitnick

Abstract read
In one paragraph

Article in Lancet (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 7 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 7 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2017
    Pooled it
  4. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Active case finding in contacts of people with tuberculosis.The Cochrane database of systematic reviews · 2011
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Observational
  15. 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  16. Review
  17. Caregiver willingness to give TPT to children living with drug-resistant TB patients.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mercedes C BecerraDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA. mbecerra@post.harvard.edu
Sasha C Appleton
Molly F Franke
Katiuska Chalco
Fernando Arteaga
Jaime Bayona
Megan Murray
Sidney S Atwood
Carole D Mitnick
Partners In Health · USBrigham and Women's Hospital · USHarvard University · US

Funding

Molecular epidemiology of drug-resistant tuberculosis in PeruK01HL080939 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BECERRA, MERCEDES C · 2005 to 2009
$680k
Clinical Outcomes Research in MDR-TBK01AI065836 · NIAID · HARVARD MEDICAL SCHOOL · PI MITNICK, CAROLE D. · 2006 to 2008
$346k
NHLBI NIH HHS K01 HL080939NIAID NIH HHS K01 AI065836PHS HHS K01 A1065836
6 · The paper itself

Abstract

backgroundMultidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have emerged as major global health threats. WHO recommends contact investigation in close contacts of patients with MDR and XDR tuberculosis. We aimed to assess the burden of tuberculosis disease in household contacts of such patients.

methodsWe undertook a retrospective cohort study of household contacts of patients treated for MDR or XDR tuberculosis in Lima, Peru, in 1996-2003. The primary outcome was active tuberculosis in household contacts at the time the index patient began MDR tuberculosis treatment and during the 4-year follow-up. We examined whether the occurrence of active tuberculosis in the household contacts differed by resistance pattern of the index patient: either MDR or XDR tuberculosis.

findings693 households of index patients with MDR tuberculosis were enrolled in the study. In 48 households, the Mycobacterium tuberculosis isolate from the index patient was XDR. Of the 4503 household contacts, 117 (2·60%) had active tuberculosis at the time the index patient began MDR tuberculosis treatment-there was no difference in prevalence between XDR and MDR tuberculosis households. During the 4-year follow-up, 242 contacts developed active tuberculosis-the frequency of active tuberculosis was nearly two times higher in contacts of patients with XDR tuberculosis than it was in contacts of patients with MDR tuberculosis (hazard ratio 1·88, 95% CI 1·10-3·21). In the 359 contacts with active tuberculosis, 142 (40%) had had isolates tested for resistance against first-line drugs, of whom 129 (90·9%, 95% CI 85·0-94·6) had MDR tuberculosis.

interpretationIn view of the high risk of disease recorded in household contacts of patients with MDR or XDR tuberculosis, tuberculosis programmes should implement systematic household contact investigations for all patients identified as having MDR or XDR tuberculosis. If shown to have active tuberculosis, these household contacts should be suspected as having MDR tuberculosis until proven otherwise.

fundingThe Charles H Hood Foundation, the David Rockefeller Center for Latin American Studies at Harvard University, and the Bill & Melinda Gates Foundation.

Indexed as

Contact TracingCost of IllnessFamily CharacteristicsPopulation SurveillanceAdolescentAdultAgedAntitubercular AgentsChildCohort StudiesExtensively Drug-Resistant TuberculosisFemaleHumansInfection ControlMaleMiddle AgedAntitubercular Agents

Identifiers

PMID21145581
PMCPMC13508782
OpenAlexW2110680787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.